TY  - JOUR

T1  - The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses.

JO  - Platelets

PY  - 2008/03/01

AU  - Judge HM

AU  - Buckland RJ

AU  - Sugidachi A

AU  - Jakubowski JA

AU  - Storey RF

ED  - 

DO  - DOI: 10.1080/09537100701694144

VL  - 19

IS  - 2

SP  - 125

EP  - 133

Y2  - 2024/12/26

ER  -